[144] Atlassian Corporation SEC Filing
Rhea-AI Filing Summary
Form 144 notice filed for proposed sale of restricted common stock on NASDAQ. The notice reports an intended sale on 08/14/2025 of 3,048 shares of common stock through Morgan Stanley Smith Barney LLC at an aggregate market value of $498,121.84. The shares were acquired as restricted stock on 08/13/2025 and payment was recorded the same day. The filer previously sold 1,770 shares on 05/19/2025 for gross proceeds of $380,320.61. The filing includes the seller's representation that they are not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine insider sale notice: small-block restricted-stock sale disclosed, no new operational data.
This Form 144 reports a planned sale of 3,048 restricted shares valued at $498,121.84 to be executed on 08/14/2025 through Morgan Stanley Smith Barney LLC. The shares were acquired one day earlier as restricted stock. From a market-impact perspective, the size of the block (3,048 shares) appears modest relative to the issuer's outstanding shares reported here (262,505,837), suggesting limited direct impact on liquidity or valuation. The filing follows Rule 144 disclosure requirements and contains the standard representation about absence of undisclosed material adverse information.
TL;DR Compliance-focused disclosure; confirms insider sale and prior recent disposition, no governance red flags shown.
The document documents a compliant notice of proposed sale under Rule 144 and records a prior sale of 1,770 shares on 05/19/2025 for $380,320.61. The rapid acquisition-and-sale timing (acquired 08/13/2025 and planned sale 08/14/2025) is disclosed; the filer also affirms no knowledge of undisclosed material adverse information. Absent other context (executive role, holding concentration, trading plan details), this filing alone does not indicate governance concerns but is useful for transparency on insider transactions.